Article may be outdated

This article is 12 days old. Some details may have changed since publication.

Headlinne
Sign inGet Headlinne
The Hindu·2 min read·medium

Granules secures FTF status for CNS depressant generic

T
The Hindu Bureau
Granules secures FTF status for CNS depressant generic
✦AI Summary

Granules India has secured sole first-to-file status for a generic version of the narcolepsy drug Lumryz. This achievement marks a significant step in the company's strategy to expand its portfolio of complex generic pharmaceuticals in the U.S. market.

Why it mattersUnlock →

Granules India has secured sole first-to-file (FTF) status for its abbreviated new drug application (ANDA) for Sodium Oxybate extended-release for oral suspension, the generic equivalent of Lumryz ER oral suspension of Alkermes plc.

Continue reading on Headlinne

Create a free account to read the full article.

Read full article →
businesshealth
Political bias analysisUnlock →
Read originalGet full access
✦

Get the full story

Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.

Create free account

Already have an account? Sign in